MT

Michaela Tsai

Physician · Providence Swedish

Credentials: · · · · ·

History

Providence Swedish
2022–Present

Hematology and Medical Oncology
University of Minnesota Medical School
1998–2001
Internal Medicine
University of Minnesota Medical School
1995–1998
Harvard Medical School
1991–1995

Research

Blood-based tumor mutational burden as a biomarker for atezolizumab in non-small cell lung cancer: the phase 2 B-F1RST trial
Nature Medicine · 2022 · 158 citations
Eribulin Plus Pembrolizumab in Patients with Metastatic Triple-Negative Breast Cancer (ENHANCE 1): A Phase Ib/II Study
Clinical Cancer Research · 2021 · 104 citations
A Phase Ib Study of Onvansertib, a Novel Oral PLK1 Inhibitor, in Combination Therapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia
Clinical Cancer Research · 2020 · 77 citations

BS
Barbara Susnik
8 papers
TL
Tamera Lillemoe
8 papers
EG
Erin Grimm
6 papers
BM
Bryan Michalowicz
3 papers
MK
Monica Knaack
3 papers
Natasha Rueth
3 papers
Sami Diab
3 papers
Anne Blaes
2 papers
FE
Francisco Esteva
2 papers
Mara Rendi
2 papers
Patrick Ward
2 papers
PR
Paul Richards
2 papers